Market Highlights
Cord blood is the blood that remains in the umbilical cord and placenta, post-delivery. Cord blood contains an abundance of stem cells and immune system cells and the medical applications of these cells have been expanding at a rapid pace.
A number of factors such as the increasing prevalence of chronic diseases, growing awareness about cord blood banking, advancement in therapeutic application, huge research funding in R&D, unmet medical needs, increasing competition among market players, and increasing government assistance are a few factors propelling the growth of the global cord blood banking services market.
Cord Blood Banking Services Market Segmentation
The global market for cord blood banking services has been segmented based on storage service, component, application, and end-user.
Based on storage service, the global market for cord blood banking services has been segmented into hybrid cord blood banks, private cord blood banks, and public cord blood banks.
Based on components, the global market for cord blood banking services has been segmented into cord blood, cord tissue, placenta, and others.
Based on the application, the global market for cord blood banking services has been segmented into cancers, immune disorders, blood disorders, metabolic disorders, and osteoporosis.
Based on end-user, the global market for cord blood banking services has been segmented into hospitals (medical applications), research institutes (scientific research), pharmaceutical research (drug discovery), and others.
Cord Blood Banking Services Market Regional Analysis
Cord Blood Banking Services Market Growth consists of four regions: the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas region held the largest market share of the global market for cord blood banking services due to the increasing number of service providers, increasing awareness of the long-term benefits of cord blood storage, increasing investment in public banking, and reduction in storage costs. In addition, the U.S. is contributing to a significant market share for the global cord blood banking industry. Factors include a rise in per capita income, an increase in the number of storage service providers, and a high acceptance rate for new technology attributed to the largest market share.
The European cord blood banking market is the second-largest market, followed by the Asia Pacific region.
The Asia Pacific region is projected to dominate the global market for cord blood banking services in terms of growth in the forecast period. Although the region currently has a small share of the global market, it is projected to have enormous growth potential as a result of increasing awareness of stem cell banking and significant improvements in health care reforms in countries such as Malaysia, India, Indonesia, and China. Moreover, Asia Pacific is a mostly unexplored regional market compared to developed regions, which is why it provides better opportunities for business growth.
The Middle East region is anticipated to expand at a steady pace due to growing R&D activities in the healthcare sector and the overall growth of healthcare infrastructure.
Cord Blood Banking Services Market Key Players
Some of the leading participants in the global cord blood banking services market are Cordlife Group Limited (Singapore), China Cord Blood Corporation (China), Cord Blood America, Inc. (U.S.), Cryo-Cell International, Inc. (U.S.), CBR Systems, Inc. (U.S.), Cryo-Save AG (Netherland), Lifeforce Cryobank Sciences Inc. (U.S.), California Cryobank Stem Cell Services LLC (U.S.), Virgin Health Bank (Qatar), StemCyte, Inc. (India), ViaCord, Inc. (U.S.), Norton Healthcare, Inc. (U.S.), CordVida (Brazil), CryoHoldco de Latinoamerica, S.A.P.I. De C.V. (Mexico), The University of Colorado Cord Blood Bank (U.S.), Vita 34 International (Germany), Maze Cord Blood Laboratories (U.S.), Lifebank USA (U.S.), Cryoviva Biotech Pvt. Ltd (India), CariCord (U.S.), Genecord (U.S.), AlphaCord (U.S.), Cells4Life (UK), Carter BloodCare (U.S.), Michigan Blood (U.S.), Viacord Processing Laboratory (VPL) (U.S.), LifeCell International Pvt. Ltd (India), FamilyCord (U.S.), Stem Cell Cryobank Inc. (U.S.), New Jersey Cord Blood Bank (U.S.), Americord Registry (U.S.), CorCell (U.S.), and others.
Related Reports
Gallstone Market Research Report- Global Forecast to 2027
Plastic Surgery & Integumentary System Procedures Market Research Report- Global Forecast to 2027
Contraceptive Pills Market Research Report- Global Forecast To 2027
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
